NCT04083599 2026-04-08GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsGenmabPhase 1/2 Active not recruiting350 enrolled
NCT07216105 2026-04-07FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsFate TherapeuticsPhase 1 Recruiting113 enrolled
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03798626 2026-04-01Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal CancersNovartisPhase 1 Completed167 enrolled
NCT04008797 2026-03-24A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorEisai Inc.Phase 1/2 Active not recruiting301 enrolled
NCT06704724 2026-03-13A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.PfizerPhase 1 Active not recruiting30 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT06447662 2026-02-25A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.PfizerPhase 1 Recruiting330 enrolled